Tomophase
Cambridge
About Tomophase
Tomophase is a private company founded in 2003 with a goal of providing innovative solutions for unmet medical needs through the use of light-based imaging and therapy. Many major advances in medicine have been marked by the introduction of new medical imaging tools, such as computed tomography, magnetic resonance imaging, and positron emission tomography. We believe that a new breakthrough, one of similar magnitude, is now within our reach ’ the use of light in guiding us to new ways of diagnosing diseases and improving our lives. Tomophase has developed and patented technology in the field of optical coherence tomography (OCT) which is capable of delivering high quality, high resolution cross-sectional tissue images in real-time. With the Tomophase Optical Coherence Tomography Imaging System (OCTIS™,) tissue structure can be observed up to 2-3 mm below the surface with remarkable clarity and without biopsy or the use of radiation, UV light or image contrast agents.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Estimated revenue: $1K – $10K
- Total funding: $4.5M
- Funding stage: Early Stage Venture
- Last round: Series A (Nov 2005)
- Website: tomophase.com
- Phone: 978-971-8888
Industries & Categories
Health Care, Medical, Medical Device
Canonical: https://fsome.com/organization/tomophase-2615268 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.